Teva Pharmaceutical (TEVA) is contemplating the sale of its women’s health unit as it seeks debt relief, Bloomberg reports.
Teva’s women’s health business could sell for $2 billion, according to the report.
Teva Pharmaceutical (TEVA) is contemplating the sale of its women’s health unit as it seeks debt relief, Bloomberg reports.
Teva’s women’s health business could sell for $2 billion, according to the report.
